Vapotherm is a global medical technology company primarily focused on the care of patients suffering from the respiratory distress. Co.'s device solutions are focused on High Velocity Nasal Insufflation (HVNI), which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems such as its Oxygen Assist Module. Co.'s Precision Flow systems include: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Co.'s Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. The VAPO stock yearly return is shown above.
The yearly return on the VAPO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the VAPO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|